BB-2516 oral inhibitor of matrix metalloproteinase: Will begin shortly a Phase II U.S. trial in ovarian cancer. A U.K. Phase II trial in ovarian and colorectal
British Biotech plc (BBIOY), Oxford, U.K.
Gathering data...
British Biotech plc (BBIOY), Oxford, U.K.